Humacyte Inc (HUMA) — Cash Flow-to-Debt Ratio
Humacyte Inc (HUMA) has a Cash Flow-to-Debt Ratio of -0.23x as of December 2025, meaning its operating cash flow of $-26.12 Million could theoretically repay 0% of its total liabilities ($113.26 Million) in one year. See Humacyte Inc (HUMA) financial flexibility to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Humacyte Inc Cash Flow-to-Debt Ratio (2019–2025)
Historical debt coverage capacity for Humacyte Inc across 7 annual periods. For the full cash flow conversion analysis, see Humacyte Inc (HUMA) cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Humacyte Inc (2019–2025)
Year-by-year debt coverage analysis for Humacyte Inc. Check Humacyte Inc (HUMA) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.93x | $-105.04 Million | $113.26 Million | ▼ -80.1% |
| 2024 | -0.51x | $-98.12 Million | $190.54 Million | ▲ +19.4% |
| 2023 | -0.64x | $-73.31 Million | $114.68 Million | ▲ +21.5% |
| 2022 | -0.81x | $-71.13 Million | $87.37 Million | ▼ -64.8% |
| 2021 | -0.49x | $-81.19 Million | $164.36 Million | ▲ +68.0% |
| 2020 | -1.54x | $-55.57 Million | $36.02 Million | ▲ +21.6% |
| 2019 | -1.97x | $-71.79 Million | $36.49 Million | — |